MedTrace Logo

In-vivo Efficacy of Patient Preoperative Prep, ZuraPrep (ZP)

NCT03782103 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 156

Last updated 2023-02-08

Study results available
· View outcomes & findings →

Summary

The objective of the study is to demonstrate the antimicrobial efficacy of the Zurex Preoperative Prep (ZuraPrep - clear) on skin flora of the abdomen and inguinal regions of human subjects.

Conditions

  • Surgical Skin Preparation

Interventions

DRUG

ZuraPrep Clear Solution

Apply topically.

DRUG

ChloraPrep

Apply topically.

DRUG

ZuraPrep Vehicle

Apply topically.

Sponsors & Collaborators

  • Zurex Pharma, Inc.

    lead INDUSTRY

Principal Investigators

  • M H Bashir, MD · Microbac Laboratories, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-25
Primary Completion
2019-05-12
Completion
2019-09-26
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03782103 on ClinicalTrials.gov